PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-39.87%
Both yoy net incomes decline, with ORCL at -18.38%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
12.85%
D&A growth well above ORCL's 15.46%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-143.82%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-0.82%
Negative yoy SBC while ORCL is 17.31%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
402.45%
Slight usage while ORCL is negative at -439.71%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
169.81%
AR growth of 169.81% while ORCL is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
-100.00%
Negative yoy inventory while ORCL is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-100.00%
Both negative yoy AP, with ORCL at -368.07%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-30.43%
Both reduce yoy usage, with ORCL at -371.58%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
83.77%
Lower 'other non-cash' growth vs. ORCL's 29120.83%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
48.78%
Operating cash flow growth below 50% of ORCL's 173.58%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-8.51%
Both yoy lines negative, with ORCL at -35.56%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-126.98%
Both yoy lines negative, with ORCL at -1553.35%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-161.65%
Both yoy lines negative, with ORCL at -45.31%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
11.55%
Below 50% of ORCL's 41.66%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
100.00%
Growth of 100.00% while ORCL is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
-6317.39%
Both yoy lines negative, with ORCL at -337.27%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
18.80%
Debt repayment growth of 18.80% while ORCL is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
339.58%
Stock issuance far above ORCL's 86.29%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
47.69%
Repurchase growth above 1.5x ORCL's 3.97%. David Dodd would see a strong per-share advantage if the share price is reasonably valued.